Patterns of response and drugs involved in hypersensitivity reactions to beta-lactams in children


Por: Torres-Rojas, I, Perez-Alzate, D, Luisa Somoza, M, Haroun Diaz, E, Ruano Perez, F, Prieto-Moreno Pfeifer, A, Jimenez-Rodriguez, T, Fernandez Sanchez, J, Blanca Gomez, M, Canto Diez, G and Blanca-Lopez, N

Publicada: 1 ago 2021 Ahead of Print: 1 ago 2021
Resumen:
Background Beta-lactams generate different allergenic determinants that induce selective or cross-reactive drug hypersensitivity reactions (DHRs). We aimed to identify the drugs involved, the selectivity of the response, the mechanism, and the value of the different diagnostic tests for establishing a diagnosis in children evaluated for DHRs to beta-lactams. Methods Prospective study evaluating children aged under 16 years reporting DHRs to beta-lactams. Reactions were classified as immediate and non-immediate reactions. The workup included sIgE, skin testing, and drug provocation tests (DPTs) for immediate reactions and patch testing and DPTs for non-immediate ones. Results Of the 510 children included, 133 were evaluated for immediate reactions and confirmed in 8.3%. Skin test/in vitro IgE contributed to diagnosing half of the cases. Selective reactions occurred with amoxicillin (63%), followed by common penicillin determinants (27%) and cephalosporins (0.9%). Among non-immediate reactions (11.4% of the 377 children evaluated), most required DPTs, 52.7% of which were positive at 6-7 days of drug challenge. Selective reactions were identified with amoxicillin (80%), penicillin G (7.5%), cephalosporins (7.5%), and clavulanic acid (5%). Urticaria and maculopapular exanthema were the most frequent entities. Conclusions There were few confirmed cases of either type of reaction. Skin testing proved less valuable in non-immediate reactions, over half of which would also have been lost in a short DPT protocol. Selective responders to amoxicillin were more likely to have non-immediate reactions, while clavulanic acid selectivity was exclusive to the non-immediate typology. Over half the cases with DPTs required 6-7 days of treatment for DHR confirmation.
ISSN: 09056157





PEDIATRIC ALLERGY AND IMMUNOLOGY
Editorial
WILEY-BLACKWELL, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Dinamarca
Tipo de documento: Article
Volumen: 32 Número: 8
Páginas: 1788-1795
WOS Id: 000684588400001
ID de PubMed: 34324747
imagen Green Submitted

MÉTRICAS